Millennium Management LLC Sells 72,884 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

Millennium Management LLC lowered its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,162,568 shares of the medical instruments supplier's stock after selling 72,884 shares during the period. Millennium Management LLC owned about 5.34% of AngioDynamics worth $19,809,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its stake in AngioDynamics by 10.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,488,667 shares of the medical instruments supplier's stock worth $13,636,000 after purchasing an additional 135,007 shares during the last quarter. Segall Bryant & Hamill LLC lifted its stake in AngioDynamics by 55.3% during the fourth quarter. Segall Bryant & Hamill LLC now owns 1,415,156 shares of the medical instruments supplier's stock worth $12,963,000 after purchasing an additional 503,713 shares during the last quarter. Royce & Associates LP lifted its stake in shares of AngioDynamics by 13.5% in the 4th quarter. Royce & Associates LP now owns 1,119,385 shares of the medical instruments supplier's stock valued at $10,254,000 after acquiring an additional 133,312 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of AngioDynamics by 1.4% in the 4th quarter. Geode Capital Management LLC now owns 974,302 shares of the medical instruments supplier's stock valued at $8,927,000 after acquiring an additional 13,535 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of AngioDynamics by 46.0% in the 4th quarter. JPMorgan Chase & Co. now owns 807,483 shares of the medical instruments supplier's stock valued at $7,397,000 after acquiring an additional 254,322 shares during the last quarter. Institutional investors own 89.43% of the company's stock.

AngioDynamics Stock Up 0.4%

Shares of NASDAQ ANGO traded up $0.04 during midday trading on Monday, reaching $9.45. The company had a trading volume of 390,130 shares, compared to its average volume of 553,720. AngioDynamics, Inc. has a one year low of $5.47 and a one year high of $13.50. The firm's fifty day moving average price is $9.47 and its 200-day moving average price is $9.53. The stock has a market cap of $383.74 million, a PE ratio of -1.68 and a beta of 0.58.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its quarterly earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The company had revenue of $72.00 million for the quarter, compared to the consensus estimate of $70.30 million. The business's quarterly revenue was down 4.3% on a year-over-year basis. As a group, equities research analysts expect that AngioDynamics, Inc. will post -0.37 EPS for the current year.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a "buy" rating and issued a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a research note on Monday, April 7th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.